We are live on ! Find out more
BLFS icon

BioLife Solutions

128 hedge funds and large institutions have $967M invested in BioLife Solutions in 2020 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 30 increasing their positions, 45 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 14

90% more call options, than puts

Call options by funds: $4.03M | Put options by funds: $2.12M

54% more capital invested

Capital invested by funds: $626M → $967M (+$341M)

19% more funds holding

Funds holding: 108128 (+20)

4.81% more ownership

Funds ownership: 69.21%74.02% (+4.8%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

33% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 45

Holders
128
Holders Change
+20
Holders Change %
+18.52%
% of All Funds
2.27%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
35
Increased
30
Reduced
45
Closed
14
Calls
$4.03M
Puts
$2.12M
Net Calls
+$1.92M
Net Calls Change
+$890K

BLFS Hedge Fund Activity: Q4 2020 in Review

128 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2020, worth a combined $967M — up 54% from $626M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new BLFS positions and 14 closed out — a net gain of 21 holders — while 30 added to existing stakes and 45 trimmed.

The largest buyer was Casdin Capital, adding an estimated $54.6M. The largest seller was Park West Asset Management, exiting entirely with an estimated $28M sold.

  • 128 institutional investors held BioLife Solutions (BLFS) as of Q4 2020, up from 108 in Q3 2020.
  • Funds reported $967M of BioLife Solutions stock for Q4 2020, up 54% quarter-over-quarter.
  • 35 funds opened new BioLife Solutions positions in Q4 2020 and 14 closed out, a net change of +21 holders.
  • The largest BioLife Solutions buyer in Q4 2020 was Casdin Capital, an estimated $54.6M added.
  • The largest BioLife Solutions seller in Q4 2020 was Park West Asset Management, an estimated $28M sold.

Based on aggregated 13F filings for Q4 2020.